Pharmaceutical Technology

SEPTEMBER 15, 2022

However, the FDA's approval of Lumakras for metastatic non-small cell lung cancer in May last year has a global analyst consensus sales forecast of $336m for this year, according to GlobalData’s Drugs Database. BioNTech (18,644.5%) and Moderna (1,842.3%) had more than 100% YoY operating income growth last year due to Covid-19 vaccine demand.

Vaccines 108

Vaccines Drug Pricing Documentation Biosimilars 108

European Pharmaceutical Review

JANUARY 18, 2024

Insomnia market Dual orexin receptor antagonists (DORAs) [dual orexin receptor antagonists (DORAs)]… offer a new mechanism of action [in treating insomnia]” Across the seven major markets, the insomnia market is anticipated to grow at a compound annual growth rate (CAGR) of 2.6 percent from $3.2 billion in 2022 to $4.1

Drug Pricing 98

Drug Pricing Biosimilars Compounding 98

European Pharmaceutical Review

JUNE 24, 2022

The review was impacted by Brexit and the COVID-19 pandemic, which compounded existing issues surrounding high drug pricing and patient access that had been brewing since 2016 and highlighted several shortcomings in the EU’s pharmaceutical system. It is too early to say because we have not seen the whole package of measures yet.

Compounding 105

Compounding Drug Development Drug Pricing Dosage 105

Pharmaceutical Technology

JUNE 6, 2025

Find out more Ro5’s platform utilises a biomedical knowledge graph containing more than 85 million nodes and 400m relationships to find new connections in biological processes and enable evaluation of drug targets based on therapeutic, biological and market potential.

Communication 52

Communication Hospitals Drug Pricing Packaging 52

STAT

APRIL 23, 2025

European pharmaceutical bosses have called on the European Union to increase drug prices toward the much higher levels paid by the U.S., Thanks to the American Rescue Plan Act, pharmaceutical companies are now required to pay that difference in the form of a rebate to the government health care program.

Compounding 234

Compounding Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 234

Pharma Marketing Network

APRIL 17, 2025

Simultaneously, lawmakers continue to call for restrictionsor outright banson direct-to-consumer (DTC) television ads for prescription drugs. Advocacy groups cite concerns over consumer safety, misinformation, and rising drug prices, fueling bipartisan momentum to reconsider how pharmaceuticals are marketed to the public.

HIPAA 59

HIPAA Drug Pricing Compounding Pharmaceutical Companies 59

pharmaphorum

JUNE 12, 2025

These closures, compounded by the decline of independent pharmacies, create a critical gap in care. Importantly, this type of insight also supports smarter negotiations around drug pricing. In communities where there is only one pharmacy – or none – there is no competition to drive down prices.

Health and Personal Care Stores 59

Health and Personal Care Stores Diabetes Pharmaceutical Companies Pharmaceutical Companies 59

Ramblings of a pharmacist

FEBRUARY 16, 2022

For example, “In the compounding period of 1941, the average pharmacy filled about 5,000 prescriptions a year, approximately 15 a day.” Each choice has bearing on the final result that Drug Channels calls out - “IQVIA data show that for 2020, the GDR for unbranded generics in the overall market was 88.5%.

Independent Pharmacies 52

Independent Pharmacies Compounding Specialty Pharmacies Prescription Filling 52

pharmaphorum

FEBRUARY 18, 2021

Drug prices to plummet in wave of expiring patents”. Price decay after loss of brand exclusivity”. These are just three headlines that come up when you Google “drug patent expiry”. Eli Lilly’s Humalog compound and formulation patents expired in 2013 and 2014, respectively. “Patent losses could sink Allergan”.

Prescription Filling 52

Prescription Filling Drug Pricing Biosimilars Compounding 52

pharmaphorum

JUNE 2, 2022

While in 2021, orphan drugs made up over half of all the US FDA’s approvals, with the figures in European being similarly high – 19 out of 54 approved new active substances. The report estimates that the orphan drug market will grow twice as fast as the non-orphan market, with a 2021 to 2026 compound annual growth rate of 12%.

Compounding 52

Compounding Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 52

Proxsys Rx

DECEMBER 11, 2023

Given that, why would a drug company want to reimburse the price of a 340B-covered specialty drug costing tens of thousands of dollars, if the provider isn’t dispensing it correctly and the patient doesn’t benefit?

Specialty Pharmacies 52

Specialty Pharmacies Hospitals Drug Pricing Labelling 52

STAT

AUGUST 15, 2024

… Medicare unveiled the results of the program’s first 10 drug price negotiations and estimated that if the prices for all of the medicines had been in effect in 2023, the U.S. Lilly and Novo previously sued more than three dozen spas, clinics, and compounding pharmacies. And of course, do keep in touch.

Compounding 288

Compounding Compounding Pharmacies Drug Pricing 288

Proxsys Rx

MARCH 1, 2024

Given that, why would a drug company want to reimburse the price of a 340B-covered specialty drug costing tens of thousands of dollars, if the provider isn’t dispensing it correctly and the patient doesn’t benefit?

Specialty Pharmacies 40

Specialty Pharmacies Hospitals Drug Pricing Labelling 40

Safe Biologics

JUNE 12, 2023

Op-ed: IRA Drug Price Controls Will Hurt Cancer Drug Development On May 18th, an op-ed by ASBM Steering Committee Member Andrew Spiegel ran in the Reading Eagle. Unfortunately, the new drug-pricing rules enacted in the Inflation Reduction Act will stymie efforts to develop new cancer treatments.

Drug Pricing 100

Drug Pricing Drug Development Compounding 100

Safe Biologics

JUNE 12, 2023

Op-ed: IRA Drug Price Controls Will Hurt Cancer Drug Development On May 18th, an op-ed by ASBM Steering Committee Member Andrew Spiegel ran in the Reading Eagle. Unfortunately, the new drug-pricing rules enacted in the Inflation Reduction Act will stymie efforts to develop new cancer treatments.

Drug Pricing 100

Drug Pricing Drug Development Compounding 100

STAT

OCTOBER 8, 2024

… A trade group representing large compounding pharmacies has sued the U.S. Food and Drug Administration for a “reckless and arbitrary” decision to remove a widely prescribed Eli Lilly drug for combating diabetes and obesity from an official shortages list , STAT tells us. ” A U.S.

Compounding 263

Compounding Compounding Pharmacies Vaccines Immunity 263

Safe Biologics

JUNE 12, 2023

Coming Soon: ASBM/GaBI Webinar on IRA’s Medicare Price Negotiation Provisions ASBM and the Generics and Biosimilars Initiative (GaBI) are in the final planning stages for the first of two webinars examining the implications for patients and healthcare providers of the recently-passed Inflation Reduction Act (IRA).

Biosimilars 130

Biosimilars Drug Pricing Compounding Drug Development 130

Safe Biologics

JUNE 12, 2023

Coming Soon: ASBM/GaBI Webinar on IRA’s Medicare Price Negotiation Provisions ASBM and the Generics and Biosimilars Initiative (GaBI) are in the final planning stages for the first of two webinars examining the implications for patients and healthcare providers of the recently-passed Inflation Reduction Act (IRA).

Biosimilars 100

Biosimilars Drug Pricing Compounding Drug Development 100

FDA Law Blog: Biosimilars

DECEMBER 3, 2023

The manufacturer’s agreement must cover all its labeler codes that contain an applicable drug or a selected drug. The primary manufacturer of a selected drug may also request CMS to terminate its agreement if they are unwilling to participate in the Medicare Drug Price Negotiation.

Labelling 105

Labelling Drug Pricing Compounding Payment Processing 105

pharmaphorum

AUGUST 27, 2020

Regulatory pressures, lengthy drug development times, and the fact that drug prices have become politicised have raised risks and cut revenue projections, leading to the biotech sector falling out of fashion.

Vaccines 122

Vaccines Drug Pricing Compounding Immunity 122

STAT

MAY 8, 2025

Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Good morning, we’ve got more news today about Vinay Prasad — let’s get into it. Read the rest…

Compounding Pharmacies 273

Compounding Pharmacies Compounding Drug Pricing Drug Development 273

STAT

DECEMBER 18, 2024

Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Good morning, my colleagues were diligently roaming the halls of Congress yesterday, talking to senators about their thoughts on RFK Jr. Read on to hear what the lawmakers said. Read the rest…

Compounding 259

Compounding Drug Pricing Drug Development 259

STAT

FEBRUARY 20, 2025

” In particular, they pointed to counterfeiters, online retailers selling active ingredients without requiring a prescription, and some compound pharmacies that “cut corners” in preparing custom-made versions of the drugs. Read the rest…

Compounding Pharmacies 318

Compounding Pharmacies Compounding Drug Pricing 318

STAT

JANUARY 6, 2025

Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Today, we have a new biotech scorecard, which lays out the next quarter’s worth of the sector’s expected stock-moving events.

Compounding 310

Compounding Drug Pricing Drug Development 310

Drug Patent Watch

DECEMBER 19, 2024

Let’s explore the key components: Active Pharmaceutical Ingredients (APIs) Patents on APIs are the foundation of any drug patent portfolio. These protect the core molecule or compound that gives a drug its therapeutic effect. Q: What role does patent portfolio management play in drug pricing?

Pharmaceutical Companies 75

Pharmaceutical Companies Pharmaceutical Companies Dosage Drug Pricing 75

Putting Patients First Blog

MAY 6, 2025

16 These groups are least able to absorb the financial burden of higher prescription drug costs resulting from tariffs and are most at risk of nonadherence, delayed treatment initiation, or complete foregone care. Food and Drug Administration, Importing Biologics and CBER Regulated Products. 17 Laryssa Mykyta and Robin A.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Generic Medicine Drug Pricing Hospitals 52

BioPharma Dive

JUNE 9, 2025

Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search Pharma Biotech FDA Clinical Trials Deals Drug Pricing Gene Therapy An article from Sponsored The golden era of GLP-1 drugs: How will it impact medicine and society? You can unsubscribe at anytime. Registered in England and Wales. TechTarget, Inc.s

Diabetes 56

Diabetes Drug Pricing Drug Development Compounding 56

Ramblings of a pharmacist

FEBRUARY 20, 2022

At the same time, we see our neighbors complain about rising drug prices, and the rising cost of health insurance: Restaurateurs complain a lot about GrubHub and their seller fees, their menu stealing, and their ghost kitchens. We complain about DIR fees. About financial middlemen who add no value but extract plenty.

Health and Personal Care Stores 40

Health and Personal Care Stores Independent Pharmacies Drug Pricing Packaging 40

Pharma Marketing Network

JUNE 8, 2020

Well the power of compound interest, you know, created a very different scenario. I think both the two major parties in the United States are really taking aim at pharma and telling them you’ve got to reduce prices. I’d like you to touch base on this a little bit of the film that you were crowdsourcing.

Health and Personal Care Stores 40

Health and Personal Care Stores Mayo Clinic Hospitals Specialty Pharmacies 40

Pharmacy Times

JUNE 12, 2025

Trump signed an executive order titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients,” with the objective of lowering drug prices, namely on branded drug products, for American consumers. How Does Drug Pricing in the US Compare With Other Countries? REFERENCES 1.

Pharmacy Technician 26

Pharmacy Technician Community Pharmacies Drug Pricing Hospitals 26

STAT

MARCH 11, 2025

The Pharmaceutical Research and Manufacturers of America led a delegation of executives to the White House last month to ask Trump for changes to a Biden-era law that allows the government to negotiate certain drug prices.

Compounding 261

Compounding Drug Pricing 261

Pharmacy Times

JUNE 16, 2025

According to Trump, patients could see cost reductions of 30% to 80%, but experts question the feasibility and practicality of implementing such a policy within the complex United States drug pricing and supply system. Kennedy Jr, is permitted to develop a new rule that ties American drug prices to those of other nations.

Pharmacy Technician 26

Pharmacy Technician Drug Pricing Insurance Coverage and Processing Compounding Pharmacies 26